Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LILRA3 anticorps (AA 219-438)

LILRA3 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1859662
  • Antigène Voir toutes LILRA3 Anticorps
    LILRA3 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 3 (LILRA3))
    Épitope
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 219-438
    Reactivité
    • 24
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 18
    • 6
    Lapin
    Clonalité
    • 20
    • 4
    Polyclonal
    Conjugué
    • 17
    • 3
    • 1
    • 1
    • 1
    • 1
    Cet anticorp LILRA3 est non-conjugé
    Application
    • 16
    • 8
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Fonction
    Polyclonal Antibody to Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against LILRA3. It has been selected for its ability to recognize LILRA3 in immunohistochemical staining and western blotting.
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3) corresdonding to Val219~Gly438 (Accession # Q8N6C8)
    Isotype
    IgG
    Top Product
    Discover our top product LILRA3 Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL Immunocytochemistry in formalin fixed cells: 5-20 μg/mL Immunohistochemistry in formalin fixed frozen section: 5-20 μg/mL Immunohistochemistry in paraffin section: 5-20 μg/mL Enzyme-linked Immunosorbent Assay: 0.05-2 μg/mL Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    LILRA3 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 3 (LILRA3))
    Autre désignation
    Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3 Produits)
    Synonymes
    anticorps CD85E, anticorps HM31, anticorps HM43, anticorps ILT-6, anticorps ILT6, anticorps LIR-4, anticorps LIR4, anticorps e3, anticorps leukocyte immunoglobulin like receptor A3, anticorps LILRA3
    Sujet
    CD85e, HM31, HM43, ILT6, LIR4, E3, CD85 antigen-like family member E, Immunoglobulin-like transcript 6, Leukocyte immunoglobulin-like receptor 4
Vous êtes ici:
Support technique